Skip to main content
Premium Trial:

Request an Annual Quote

IP Watch: Qiagen, Life Tech, Cepheid, Bio-Rad, Others Win US Patents


Eppendorf has been awarded US Patent No. 8,728,415, "Microtitration plate."

Martin Seippel is named as the inventor.

Life Technologies (Thermo Fisher Scientific) has been awarded US Patent Nos. 8,728,728 and 8,728,736, both of which are titled "Methods and compositions for multiplex PCR."

John Leamon, Mark Andersen, and Michael Thornton are named as inventors.

Pherecydes Pharma has been awarded US Patent No. 8,728,734, "Method for the random diversification of a genetic sequence while preserving the identity of some inner segments of said genetic sequence."

Francois Iris is named as the inventor.

Canadian Blood Services has been awarded US Patent No. 8,728,735, "Method for the simultaneous determination of blood group and platelet antigen genotypes."

Gregory Denomme is named as the inventor.

Rubicon Genomics has been awarded US Patent No. 8,728,737, "Attaching a stem-loop oligonucleotide to a double-stranded DNA molecule."

Vladimir Makarov, Emmanuel Kamberov, and Brendan Tarrier are named as inventors.

Cepheid has been awarded US Patent No. 8,728,765, "Closed-system multi-stage nucleic acid amplification reactions."

Jesus Ching, Ronald Chang, Douglas Dority, Jian Ping Zhang, James Wang, Wendy Wong, Kendra Paul, and Reuel Van Atta are named as inventors.

Population Genetics has been awarded US Patent No. 8,728,766, "Method of adding a DBR by primer extension."

James Casbon, Sydney Brenner, Robert Osborne, Conrad Lichtenstein, and Andreas Claas are named as inventors.

Bio-Rad has been awarded US Patent No. 8,728,987, "Filtering small nucleic acids using permeabilized cells."

Yanhong Kong, Steven Okino, and Xiangdong Meng are named as inventors.

Qiagen has been awarded US Patent No. 8,729,252, "Method for facilitating an automated isolation of a biopolymer using magnetic particles."

Ralf Himmelreich and Sabine Werner are named as inventors.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.